Women who clean at home or work face increased lung function decline

Women who work as cleaners or regularly use cleaning sprays or other cleaning products at home appear to experience a greater decline in lung function over time than women who do not clean, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

In "Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction," researchers at the University of Bergen in Norway analyzed data from 6,235 participants in the European Community Respiratory Health Survey. The participants, whose average age was 34 when they enrolled, were followed for more than 20 years.

"While the short-term effects of cleaning chemicals on asthma are becoming increasingly well documented, we lack knowledge of the long-term impact," said senior study author Cecile Svanes, MD, PhD, a professor at the university's Centre for International Health. "We feared that such chemicals, by steadily causing a little damage to the airways day after day, year after year, might accelerate the rate of lung function decline that occurs with age."

The study found that compared to women not engaged in cleaning:

  • Forced expiratory volume in one second (FEV1), or the amount of air a person can forcibly exhale in one second, declined 3.6 milliliters (ml)/year faster in women who cleaned at home and 3.9 ml/year faster in women who worked as cleaners.
  • Forced vital capacity (FVC), or the total amount of air a person can forcibly exhale, declined 4.3 ml/year faster in women who cleaned at home and 7.1 ml/year faster in women who worked as cleaners.

The authors found that the accelerated lung function decline in the women working as cleaners was "comparable to smoking somewhat less than 20 pack- years."

That level of lung impairment was surprising at first, said lead study author Øistein Svanes, a doctoral student also at the Department for Clinical Science. "However, when you think of inhaling small particles from cleaning agents that are meant for cleaning the floor and not your lungs, maybe it is not so surprising after all."

The authors speculate that the decline in lung function is attributable to the irritation that most cleaning chemicals cause on the mucous membranes lining the airways, which over time results in persistent changes in the airways and airway remodeling.

The study did not find that the ratio of FEV1 to FVC declined more rapidly in women who cleaned than in those who did not. The metric is used when diagnosing and monitoring patients with chronic obstructive pulmonary disease, or COPD. The study did find that asthma was more prevalent in women who cleaned at home (12.3 percent) or at work (13.7 percent) compared to those who did not clean (9.6 percent).

The study also did not find that men who cleaned, either at home or at work, experienced greater decline in FEV1 or FVC than men who did not.

The researchers took into account factors that might have biased the results, including smoking history, body mass index and education.

Study limitations include the fact that the study population included very few women who did not clean at home or work. These women, the authors wrote, might "constitute a selected socioeconomic group." The number of men who worked as occupational cleaners was also small, and their exposure to cleaning agents was likely different from that of women working as cleaning professionals.

"The take home message of this study is that in the long run cleaning chemicals very likely cause rather substantial damage to your lungs," Øistein Svanes said. "These chemicals are usually unnecessary; microfiber cloths and water are more than enough for most purposes."

He added that public health officials should strictly regulate cleaning products and encourage producers to develop cleaning agents that cannot be inhaled.

Øistein Svanes, Randi J Bertelsen, Stein HL Lygre, Anne E Carsin, Josep M Antó, Bertil Forsberg, José M García-García, José A Gullón, Joachim Heinrich, Mathias Holm, Manolis Kogevinas, Isabel Urrutia, Bénédicte Leynaert, Jesús M Moratalla, Nicole Le Moual, Theodore Lytras, Dan Norbäck, Dennis Nowak, Mario Olivieri, Isabelle Pin, Nicole Probst-Hensch, Vivi Schlünssen, Torben Sigsgaard, Trude D Skorge, Simona Villani, Debbie Jarvis, Jan P Zock, Cecilie Svanes.
Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction.
American Journal of Respiratory and Critical Care Medicine. doi: 10.1164/rccm.201706-1311OC.

Most Popular Now

Pfizer begins a Phase 1/2 study to evaluate respir…

Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV i...

Eczema drug effective against severe asthma

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe bett...

Most popular vitamin and mineral supplements provi…

The most commonly consumed vitamin and mineral supplements provide no consistent health benefit or harm, suggests a new study led by researchers at St. Michael's Hospital...

AstraZeneca heads to 2018 ASCO Annual Meeting with…

AstraZeneca and MedImmune, its global biologics research and development arm, head to the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, US...

Tiny particles could help fight brain cancer

Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median ...

Novartis data at ASCO and EHA reinforce company's …

Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 1-5 ...

Spiolto® Respimat® enables greater physical activi…

Boehringer Ingelheim announced data which add to the growing body of evidence that show Spiolto® (tiotropium/olodaterol) Respimat® enables greater physical activity in pa...

New approach to immunotherapy leads to complete re…

A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was...

Amgen Foundation and Harvard team up to offer free…

The Amgen Foundation and Harvard University today announced plans to launch a free online science education platform uniquely designed to level the playing field for aspi...

The Pfizer Foundation announces $5 million in gran…

The Pfizer Foundation announced a new $5 million grant commitment to initiatives in low- and middle-income countries that provide family planning access and education for...

Study demonstrates new treatment for severe asthma

Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering ...

Study finds antioxidant-enriched vitamin reduces r…

Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado School of Medicine have found that taking a specially formulated antioxid...